Observational studyFuture oncology (London, England)2026

Real-world treatment patterns and outcomes of patients with multiple myeloma initiating elranatamab: results from the ALTITUDE-1 and ALTITUDE-2 retrospective cohort studies.

Rahul Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.